135 related articles for article (PubMed ID: 32425685)
21. Identification of hnRNP C1/C2 as an Autoantigen in Patients with Behcet's Disease.
Hussain M; Xiao J; Zhang Y; Chen P; Du H
Iran J Immunol; 2018 Jun; 15(2):133-141. PubMed ID: 29947342
[TBL] [Abstract][Full Text] [Related]
22. Redistribution of the nuclear mitotic apparatus protein (NuMA) during mitosis and nuclear assembly. Properties of purified NuMA protein.
Price CM; Pettijohn DE
Exp Cell Res; 1986 Oct; 166(2):295-311. PubMed ID: 3527729
[TBL] [Abstract][Full Text] [Related]
23. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease.
Lee KH; Bang D; Choi ES; Chun WH; Lee ES; Lee S
Arch Dermatol Res; 1999; 291(7-8):374-81. PubMed ID: 10482005
[TBL] [Abstract][Full Text] [Related]
24. Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell.
Lydersen BK; Pettijohn DE
Cell; 1980 Nov; 22(2 Pt 2):489-99. PubMed ID: 7004645
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance.
Bonaci-Nikolic B; Andrejevic S; Bukilica M; Urosevic I; Nikolic M
J Clin Immunol; 2006 Sep; 26(5):438-46. PubMed ID: 16941236
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to nuclear mitotic apparatus in a patient with vitiligo and autoimmune thyroiditis.
Auer-Grumbach P; Stangl M
Dermatology; 1993; 186(3):229-31. PubMed ID: 8453154
[TBL] [Abstract][Full Text] [Related]
27. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease.
Vural B; Sehitoğlu E; Cavuş F; Yalçınkaya N; Haytural H; Küçükerden M; Ulusoy C; Uğurel E; Turan S; Bulut L; Türkoğlu R; Shugaiv E; Kürtüncü M; Atakan S; Güre AO; Gül A; Eraksoy M; Akman-Demir G; Tüzün E
J Neuroimmunol; 2013 Oct; 263(1-2):139-44. PubMed ID: 24035008
[TBL] [Abstract][Full Text] [Related]
29. Nuclear proteins that become part of the mitotic apparatus: a role in nuclear assembly?
Pettijohn DE; Henzl M; Price C
J Cell Sci Suppl; 1984; 1():187-201. PubMed ID: 6597818
[TBL] [Abstract][Full Text] [Related]
30. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.
Park YK; Kim NS; Hann SK; Im S
J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031
[TBL] [Abstract][Full Text] [Related]
31. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
[TBL] [Abstract][Full Text] [Related]
32. Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease.
Chen P; Yan H; Tian Y; Xun Y; Shi L; Bao R; Zhang H; Chen G; Yang C; Sun S; Wang Y; Liu L; Zhou Y; Zhang C; Wang X; Wen Y; Bian Y; Du H
Sci Rep; 2015 Feb; 5():8162. PubMed ID: 25641213
[TBL] [Abstract][Full Text] [Related]
33. Behçet's disease and antibody titers to various heat-shock protein 60s.
Tanaka T; Yamakawa N; Koike N; Suzuki J; Mizuno F; Usui M
Ocul Immunol Inflamm; 1999 Jun; 7(2):69-74. PubMed ID: 10420201
[TBL] [Abstract][Full Text] [Related]
34. Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A
Anticancer Res; 1999; 19(4A):2415-20. PubMed ID: 10470168
[TBL] [Abstract][Full Text] [Related]
35. [A study of antiendothelial cell antibodies in Behcet's disease].
Zheng WJ; Zhao Y; Tang FL; Dong Y
Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
[TBL] [Abstract][Full Text] [Related]
36. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
[TBL] [Abstract][Full Text] [Related]
37. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
38. Antiannexin V autoantibody in thrombophilic Behçet's disease.
Aslan H; Pay S; Gok F; Baykal Y; Yilmaz MI; Sengul A; Aydin HI
Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
[TBL] [Abstract][Full Text] [Related]
40. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
